STRS Ohio’s Oramed Pharmaceuticals ORMP Stock Holding History

STRS Ohio’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,400	Closed	-$46K	–	2216
2022 Q1	$46K	Sell	5,400 -3,900	-42%	-$40K	﹤0.01%	1954
2021 Q4	$132K	Hold	9,300	–	–	﹤0.01%	1836
2021 Q3	$204K	Buy	9,300 +3,100	+50%	+$52.8K	﹤0.01%	1761
2021 Q2	$82K	Buy	+6,200	New	+$70.9K	﹤0.01%	2019

Other funds holding ORMP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

STRS Ohio's ORMP Position: Q2 2022 in Review

STRS Ohio sold out of Oramed Pharmaceuticals (ORMP) in Q2 2022, closing a stake of 5,400 shares — an estimated $46K sold.

STRS Ohio first reported a position in ORMP in Q2 2021 and held it in 4 quarters. The position peaked at $204K in Q3 2021. 88 funds tracked by Wall St. Rank hold ORMP as of Q2 2022.

STRS Ohio reported no remaining Oramed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
STRS Ohio sold 5,400 Oramed Pharmaceuticals shares in Q2 2022, an estimated $46K.
STRS Ohio first reported a position in Oramed Pharmaceuticals in Q2 2021 and held it in 4 quarters.
STRS Ohio's Oramed Pharmaceuticals position peaked at $204K in Q3 2021.
88 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.